Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How has the pharmaceuticals native starch market size changed in recent years, and what is the outlook ahead?
The pharmaceuticals native starch market size has grown strongly in recent years. It will grow from $5.65 billion in 2024 to $6.17 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increased demand for natural excipients, growing pharmaceutical production, rising preference for biocompatible ingredients, expansion of generic drug manufacturing, and growing regulatory support for natural ingredients.
The pharmaceuticals native starch market size is expected to see strong growth in the next few years. It will grow to $8.69 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to rising investment in pharmaceutical innovation, growing focus on sustainable sourcing, expanding applications in novel drug formulations, increasing demand for clean-label pharmaceutical products, and rising healthcare expenditure in emerging markets. Major trends in the forecast period include technology advancements in starch processing, innovations in drug delivery systems, developments in bio-based pharmaceutical ingredients, research and development in plant-based excipients, and development of solubility and stability solutions.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp
What are the top economic and technological drivers pushing pharmaceuticals native starch market growth?
The increasing prevalence of chronic diseases is expected to propel the growth of the pharmaceuticals native starch market going forward. Chronic diseases are long-lasting medical conditions that typically progress slowly and persist for a year or more. The increasing prevalence of chronic diseases is primarily attributed to the rising aging population, as older individuals are more susceptible to long-term health conditions such as diabetes, cardiovascular diseases, arthritis, and cancer, which tend to become more common with age. Pharmaceuticals native starch is helpful for chronic diseases by improving drug formulation stability, enhancing bioavailability, enabling controlled drug release, supporting patient compliance, and ultimately strengthening the effectiveness and long-term management of chronic medical conditions. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the death rate from chronic conditions saw a increase, rising from 459 per 100,000 people in 2021 to 490 per 100,000 people in 2022. Therefore, the increasing prevalence of chronic diseases is driving the growth of the pharmaceuticals native starch market.
How is the pharmaceuticals native starch market segmented by product, application, and end-user?
The pharmaceuticals native starch market covered in this report is segmented –
1) By Type: Potato Starch, Corn Starch, Other Types
2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations
3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent
4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents
5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users
Subsegments:
1) By Potato Starch: Modified Potato Starch, Native Potato Starch
2) By Corn Starch: Modified Corn Starch, Native Corn Starch
3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report
What technological trends are expected to redefine the pharmaceuticals native starch market?
Major companies operating in the pharmaceuticals native starch market are focusing on developing innovative products, such as plant-based textures, to enhance drug formulation and improve patient compliance. Plant-based texture refers to the physical properties derived from plant ingredients, such as thickness and gel strength, and helps pharmaceuticals use native starch by enhancing tablet binding, disintegration, and mouthfeel for improved natural drug formulations. For instance, in February 2024, Ingredion Incorporated, a US-based food company, launched Novation Indulge 2940 starch, a clean-label texturizer designed to enhance texture and stability in dairy and alternative dairy products. This innovative pharmaceutical native starch offers functional properties that enhance drug formulation performance, bioavailability, and controlled release while supporting the development of clean-label, sustainable products. NOVATION Indulge 2940 starch is a versatile ingredient that improves texture, stability, and consumer acceptance in both dairy and alternative dairy products, using clean-label, natural ingredients.
Which leading companies are dominating the pharmaceuticals native starch market landscape?
Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Tereos SCA, Roquette Frères SA., AGRANA, Tate & Lyle Public Limited Company, Colorcon Inc., Grain Processing Corporation, Siam Modified Starch Co. Ltd., BENEO GmbH, Gulshan Polyols Ltd., SPAC Starch Products (India) Private Limited, Universal Starch-Chem Allied Ltd., Sanstar Biopolymers Ltd., Emsland Group, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Shandong Liujia Pharmaceutical Excipient Co.Ltd.
Which geographic areas are expected to offer the highest growth opportunities in thepharmaceuticals native starch market?
North America was the largest region in the pharmaceuticals native starch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Pharmaceuticals Native Starch Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24376&type=smp
Need Customized Data On Pharmaceuticals Native Starch Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
